172 related articles for article (PubMed ID: 21159570)
21. Effect of hormone replacement therapy in matrix metalloproteinase expression and intimal hyperplasia development after vascular injury.
Mountain DJ; Freeman MB; Kirkpatrick SS; Cook RB; Chalk JE; Stevens SL; Goldman MH; Grandas OH
Ann Vasc Surg; 2013 Apr; 27(3):337-45. PubMed ID: 23088810
[TBL] [Abstract][Full Text] [Related]
22. Rosuvastatin given during reperfusion decreases infarct size and inhibits matrix metalloproteinase-2 activity in normocholesterolemic and hypercholesterolemic rabbits.
D'Annunzio V; Donato M; Erni L; Miksztowicz V; Buchholz B; Carrión CL; Schreier L; Wikinski R; Gelpi RJ; Berg G; Basso N
J Cardiovasc Pharmacol; 2009 Feb; 53(2):137-44. PubMed ID: 19188835
[TBL] [Abstract][Full Text] [Related]
23. Elevated vascular angiotensin converting enzyme mediates increased neointima formation after balloon injury in spontaneously hypertensive rats.
Jandeleit-Dahm K; Burrell LM; Johnston CI; Koch KM
J Hypertens; 1997 Jun; 15(6):643-50. PubMed ID: 9218184
[TBL] [Abstract][Full Text] [Related]
24. Direct vascular and cardioprotective effects of rosuvastatin, a new HMG-CoA reductase inhibitor.
Jones SP; Gibson MF; Rimmer DM; Gibson TM; Sharp BR; Lefer DJ
J Am Coll Cardiol; 2002 Sep; 40(6):1172-8. PubMed ID: 12354446
[TBL] [Abstract][Full Text] [Related]
25. The HMG-CoA reductase inhibitor rosuvastatin and the angiotensin receptor antagonist candesartan attenuate atherosclerosis in an apolipoprotein E-deficient mouse model of diabetes via effects on advanced glycation, oxidative stress and inflammation.
Calkin AC; Giunti S; Sheehy KJ; Chew C; Boolell V; Rajaram YS; Cooper ME; Jandeleit-Dahm KA
Diabetologia; 2008 Sep; 51(9):1731-40. PubMed ID: 18594792
[TBL] [Abstract][Full Text] [Related]
26. Protective effects of rosuvastatin in a rat model of lung contusion: Stimulation of the cyclooxygenase 2-prostaglandin E-2 pathway.
Dolkart O; Amar E; Shapira S; Marmor S; Steinberg EL; Weinbroum AA
Surgery; 2015 May; 157(5):944-53. PubMed ID: 25724093
[TBL] [Abstract][Full Text] [Related]
27. Rosuvastatin increases extracellular adenosine formation in humans in vivo: a new perspective on cardiovascular protection.
Meijer P; Oyen WJ; Dekker D; van den Broek PH; Wouters CW; Boerman OC; Scheffer GJ; Smits P; Rongen GA
Arterioscler Thromb Vasc Biol; 2009 Jun; 29(6):963-8. PubMed ID: 19359665
[TBL] [Abstract][Full Text] [Related]
28. Acceleration of re-endothelialization and inhibition of neointimal formation using hybrid biodegradable nanofibrous rosuvastatin-loaded stents.
Lee CH; Chang SH; Lin YH; Liu SJ; Wang CJ; Hsu MY; Hung KC; Yeh YH; Chen WJ; Hsieh IC; Wen MS
Biomaterials; 2014 May; 35(15):4417-27. PubMed ID: 24582553
[TBL] [Abstract][Full Text] [Related]
29. Difference in statin effects on neointimal coverage after implantation of drug-eluting stents.
Yamamoto H; Ikuta S; Kobuke K; Yasuda M; Ikeda T; Yamaji K; Ueno M; Iwanaga Y; Miyazaki S
Coron Artery Dis; 2014 Jun; 25(4):290-5. PubMed ID: 24614628
[TBL] [Abstract][Full Text] [Related]
30. Rosuvastatin attenuates angiotensin II-induced neointimal formation after stent implantation in the rat.
van der Harst P; Groenewegen HC; Roks AJ; Buikema H; Zijlstra F; van Gilst WH; de Smet BJ
Coron Artery Dis; 2008 Feb; 19(1):47-53. PubMed ID: 18281816
[TBL] [Abstract][Full Text] [Related]
31. Rosuvastatin, a new HMG-CoA reductase inhibitor, protects ischemic reperfused myocardium in normocholesterolemic rats.
Ikeda Y; Young LH; Lefer AM
J Cardiovasc Pharmacol; 2003 Apr; 41(4):649-56. PubMed ID: 12658068
[TBL] [Abstract][Full Text] [Related]
32. Statins alleviate experimental nerve injury-induced neuropathic pain.
Shi XQ; Lim TKY; Lee S; Zhao YQ; Zhang J
Pain; 2011 May; 152(5):1033-1043. PubMed ID: 21414721
[TBL] [Abstract][Full Text] [Related]
33. A novel CD147 inhibitor, SP-8356, reduces neointimal hyperplasia and arterial stiffness in a rat model of partial carotid artery ligation.
Pahk K; Noh H; Joung C; Jang M; Song HY; Kim KW; Han K; Hwang JI; Kim S; Kim WK
J Transl Med; 2019 Aug; 17(1):274. PubMed ID: 31429778
[TBL] [Abstract][Full Text] [Related]
34. Bis (aspirinato) zinc (II) complex successfully inhibits carotid arterial neointima formation after balloon-injury in rats.
Hegedűs P; Korkmaz S; Radovits T; Schmidt H; Li S; Yoshikawa Y; Yasui H; Merkely B; Karck M; Szabó G
Cardiovasc Drugs Ther; 2014 Dec; 28(6):533-9. PubMed ID: 25129612
[TBL] [Abstract][Full Text] [Related]
35. Rosuvastatin reduces rat intestinal ischemia-reperfusion injury associated with the preservation of endothelial nitric oxide synthase protein.
Naito Y; Katada K; Takagi T; Tsuboi H; Kuroda M; Handa O; Kokura S; Yoshida N; Ichikawa H; Yoshikawa T
World J Gastroenterol; 2006 Apr; 12(13):2024-30. PubMed ID: 16610051
[TBL] [Abstract][Full Text] [Related]
36. Effects of rosuvastatin on the production and activation of matrix metalloproteinase-2 and migration of cultured rat vascular smooth muscle cells induced by homocysteine.
Shi YF; Chi JF; Tang WL; Xu FK; Liu LB; Ji Z; Lv HT; Guo HY
J Zhejiang Univ Sci B; 2013 Aug; 14(8):696-704. PubMed ID: 23897788
[TBL] [Abstract][Full Text] [Related]
37. ADAMTS-7 mediates vascular smooth muscle cell migration and neointima formation in balloon-injured rat arteries.
Wang L; Zheng J; Bai X; Liu B; Liu CJ; Xu Q; Zhu Y; Wang N; Kong W; Wang X
Circ Res; 2009 Mar; 104(5):688-98. PubMed ID: 19168437
[TBL] [Abstract][Full Text] [Related]
38. Rosuvastatin prevents myocardial necrosis in an experimental model of acute myocardial infarction.
Dourado PM; Tsutsui JM; Landim MB; Casella Filho A; Galvao TF; Aiello VD; Mathias W; da Luz PL; Chagas AC
Braz J Med Biol Res; 2011 May; 44(5):469-76. PubMed ID: 21445530
[TBL] [Abstract][Full Text] [Related]
39. Short-term rosuvastatin therapy for prevention of contrast-induced acute kidney injury in patients with diabetes and chronic kidney disease.
Han Y; Zhu G; Han L; Hou F; Huang W; Liu H; Gan J; Jiang T; Li X; Wang W; Ding S; Jia S; Shen W; Wang D; Sun L; Qiu J; Wang X; Li Y; Deng J; Li J; Xu K; Xu B; Mehran R; Huo Y
J Am Coll Cardiol; 2014 Jan 7-14; 63(1):62-70. PubMed ID: 24076297
[TBL] [Abstract][Full Text] [Related]
40. METEOR Trial Reports on the Effect of Rosuvastatin on Progression of Carotid Intima-Media Thickness in Low-Risk Individuals with Subclinical Atherosclerosis.
Haddad RM; Ballantyne CM
Phys Sportsmed; 2010 Jun; 38(2):180-2. PubMed ID: 20631478
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
